Outcomes of Cesarean Myomectomies Performed at a Tertiary Care Hospital in North India: A Series of 10 Cases

印度北部一家三级医院剖宫产子宫肌瘤切除术的结局:10例病例系列研究

阅读:1

Abstract

Background Uterine fibroids are common benign tumors in reproductive-aged women, and their prevalence in pregnancy is increasing. While cesarean myomectomy (CM) has traditionally been discouraged due to concerns about intraoperative hemorrhage and maternal morbidity, emerging evidence suggests it can be safely performed in selected cases. This retrospective case series evaluates the clinical outcomes of CM performed at a tertiary care center in North India over two years. Methods A total of 10 pregnant women who underwent CM were included in this study. Data were collected retrospectively from hospital records, including demographic details, indications for CM, fibroid characteristics, intraoperative parameters, and postoperative outcomes. Descriptive statistical analysis was used to summarize the findings. Results The mean maternal age was 34.5 years (range: 27-40 years), and the gestational age at delivery varied from 35 weeks and 4 days to 38 weeks and 6 days. The most common indication for cesarean section was fibroid-related concerns, including lower uterine segment (LUS) fibroids, multiple fibroids, and fibroids in patients with prior cesarean deliveries. Fibroid numbers ranged from one to fifteen per patient, with intramural fibroids (FIGO 4) being the most frequent type. The mean intraoperative blood loss was 620 mL (range: 450-800 mL), with no case of postpartum hemorrhage. The mean operative time was 74 minutes, and two patients required blood transfusions. No patients required intensive care, and the average hospital stay was 3.6 days. Neonatal outcomes were favorable, with a mean birth weight of 2.92 kg and reassuring APGAR scores. Three neonates required NICU admission for transient tachypnea, small for gestational age, and meconium aspiration syndrome. Conclusion CM, when performed in appropriately selected cases, is a feasible and safe procedure. It eliminates the need for a second surgery, reduces future fibroid-related complications, and does not significantly increase maternal morbidity. These findings support the growing consideration of CM as a viable surgical option in select cases. Further prospective studies are needed to establish standardized protocols for patient selection and surgical technique.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。